Live Events
Algorithms
Breast Cancer
2022
2023
2024
2025
GI
2022
2023
2024
2025
GU
2023
2024
2025
Gynecology
2024
Hematology
2023
2024
2025
Lung Cancer
2023
2024
2025
Melanoma
2023
2024
2025
NET
2024
2025
Supportive Care
2024
Conferences
AACR
2023
ASCO
2022
2023
2024
2025
ASH
2022
2023
2024
ESMO
2022
2023
2024
ELCC
2025
GI ASCO
2024
2025
GU ASCO
2023
2024
2025
SABCS
2022
2023
2024
WCLC
2022
2023
2024
2025
Journal club
Breast Cancer
2022
2023
2024
GI
2023
2024
2025
GU
2023
2024
2025
Hematology
2023
2024
Lung Cancer
2024
2025
Challenging Cases
2025
Tox Check
2024
2025
Multi-D Rounds
Contact
Calendar
☰ Menu
Home
Live Events
Algorithms
+
Breast Cancer
GI
GU
Gynecology
Hematology
Lung Cancer
Melanoma
NET
Supportive Care
Conferences
+
AACR
ASCO
ASH
ESMO
ELCC
GI ASCO
GU ASCO
SABCS
WCLC
Journal club
+
Breast Cancer
GI
GU
Hematology
Lung Cancer
Challenging Cases
+
2025
Tox Check
+
2024
2025
Multi-D Rounds
Contact
Calendar
Short Clips from AIO
Home
Conferences
GU ASCO
2025
Short Clips from AIO
Short Clips from AIO
Explore All
Which Androgen Receptor Pathway Inhibitors (ARPI) to Pick for Treatment of Prostate Cancer
Utilizing PSMA PET in Prostate Cancer & Intermittent Hormone Therapy for Biochemical Recurrence
Impact of Social Vulnerability on GU Cancer Patients & IRA Part D Redesign
Importance of NGS/Genetics Testing & Role of CONTACT-02 in Prostate Cancer
How to Treat Adjuvant or Metastatic Kidney Cancer?
Role of Immunotherapy in Adjuvant and Metastatic Kidney Cancer
HRDsig+ and the Genomic Landscape of Clinically Advanced Prostate Cancer
Role of NGS and Targeted Therapies Available in Bladder Cancer
Evaluation of Oligometastatic Prostate Cancer Patients Managed with Radiation Therapy
Current Standard of Care and Future Direction in Bladder Cancer
↑
This website uses
Cookies
to ensure you receive the best experience.
I Agree
No Thanks